Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

CABA | Cabaletta Bio Inc

Index	RUT	P/E	-	EPS (ttm)	-1.74	Insider Own	22.47%	Shs Outstand	39.80M	Perf Week	-3.79%
Market Cap	605.76M	Forward P/E	-	EPS next Y	-1.71	Insider Trans	-0.73%	Shs Float	30.86M	Perf Month	6.43%
Income	-57.46M	PEG	-	EPS next Q	-0.39	Inst Own	73.06%	Short Float / Ratio	10.17% / 5.17	Perf Quarter	17.89%
Sales	0.00M	P/S	-	EPS this Y	8.73%	Inst Trans	-22.17%	Short Interest	3.14M	Perf Half Y	114.37%
Book/sh	4.38	P/B	3.48	EPS next Y	-3.80%	ROA	-40.09%	Target Price	23.00	Perf Year	2235.43%
Cash/sh	4.43	P/C	3.44	EPS next 5Y	-	ROE	-42.61%	52W Range	0.61 - 19.34	Perf YTD	64.54%
Dividend	-	P/FCF	-	EPS past 5Y	-180.48%	ROI	-32.62%	52W High	-21.30%	Beta	2.49
Dividend %	-	Quick Ratio	20.94	Sales past 5Y	0.00%	Gross Margin	-	52W Low	2395.08%	ATR	1.22
Employees	60	Current Ratio	20.94	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	51.71	Volatility	6.30% 9.34%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	16.97%	Profit Margin	-	Rel Volume	0.98	Prev Close	15.20
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Aug 10 BMO	Payout	-	Avg Volume	607.12K	Price	15.22
Recom	1.00	SMA20	0.07%	SMA50	9.36%	SMA200	38.11%	Volume	596,822	Change	0.13%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-05-23	Initiated	Citigroup	Buy	$22
Jul-18-23	Initiated	Guggenheim	Buy	$34
Jan-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$3 → $16
Aug-30-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$15 → $3
Dec-08-21	Initiated	Wells Fargo	Overweight	$17
Oct-19-21	Resumed	Morgan Stanley	Overweight	$20
Jun-30-21	Initiated	Mizuho	Buy	$22
Jan-08-21	Initiated	Chardan Capital Markets	Buy	$21
Oct-13-20	Initiated	H.C. Wainwright	Buy	$20
Nov-19-19	Initiated	Morgan Stanley	Overweight	$19
Nov-19-19	Initiated	Evercore ISI	Outperform	$25
Nov-19-19	Initiated	Cowen	Outperform

Show Previous Ratings

Sep-25-23 08:50AM	What Makes Cabaletta Bio, Inc. (CABA) a Good Fit for 'Trend Investing' (Zacks)
Sep-19-23 08:00AM	Cabaletta Bio to Participate in Upcoming Investor Conferences in September (GlobeNewswire) -6.92%
Sep-01-23 02:00PM	Top Growth Stocks for September 2023 (Investopedia) -5.93%
11:30AM	Top Stocks for September 2023 (Investopedia)
Aug-31-23 09:55AM	Wall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade (Zacks)
08:30AM	Loading…
08:30AM	The 7 Most Promising Momentum Stocks to Own Now (InvestorPlace)
Aug-30-23 08:00AM	Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September (GlobeNewswire)
Aug-25-23 10:13AM	Lab Notes: Wistar, Coriell researchers identify potential target for gastric cancers treatment (American City Business Journals)
Aug-23-23 08:50AM	Recent Price Trend in Cabaletta Bio, Inc. (CABA) is Your Friend, Here's Why (Zacks)
Aug-22-23 08:00AM	Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201 (GlobeNewswire)
Aug-15-23 01:46PM	Does Cabaletta Bio, Inc. (CABA) Have the Potential to Rally 27.85% as Wall Street Analysts Expect? (Zacks)
Aug-10-23 07:00AM	Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-23 10:00AM	Top Stocks for August 2023 (Investopedia) -7.27%
Jul-24-23 08:00AM	Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors (GlobeNewswire) -6.68%
Jul-18-23 02:58PM	Why Shares of Cabaletta Bio Are Up Tuesday (Motley Fool) +11.93%
08:00AM	Loading…
Jun-20-23 08:00AM	Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors (GlobeNewswire) -5.26%
Jun-08-23 11:14AM	Top Healthcare Stocks for June 2023 (Investopedia)
May-31-23 08:00AM	Cabaletta Bio to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-24-23 07:33AM	Institutional investors in Cabaletta Bio, Inc. (NASDAQ:CABA) lost 18% last week but have reaped the benefits of longer-term growth (Simply Wall St.)
May-22-23 04:30PM	Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)
May-17-23 10:16PM	Cabaletta Bio Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -7.83%
04:01PM	Cabaletta Bio Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-16-23 07:00AM	Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis (GlobeNewswire) +14.63%
May-11-23 08:39AM	Top Healthcare Stocks for May 2023 (Investopedia) +6.67%
07:00AM	Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-02-23 04:35PM	Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting (GlobeNewswire)
May-01-23 07:00AM	Cabaletta Bio Receives FDA Fast Track Designation for CABA-201 (GlobeNewswire) +9.83%
Apr-25-23 01:07PM	Great news for Cabaletta Bio, Inc. (NASDAQ:CABA): Insiders acquired stock in large numbers last year (Simply Wall St.) -5.94%
08:00AM	Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-13-23 04:30PM	Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
07:00AM	Loading…
Mar-31-23 07:00AM	Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus (GlobeNewswire) +16.48%
Mar-16-23 07:00AM	Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-14-23 07:14AM	We're Keeping An Eye On Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate (Simply Wall St.) +8.02%
Feb-28-23 08:00AM	Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-19-23 10:53AM	TipRanks Perfect 10 List: Theres an Opportunity Brewing in These 2 Stocks (TipRanks)
Feb-17-23 06:43PM	12 Most Promising Micro-Cap Stocks According to Analysts (Insider Monkey)
Feb-06-23 12:00PM	Here's Why Cabaletta Bio, Inc. (CABA) is a Great Momentum Stock to Buy (Zacks)
Jan-31-23 09:40AM	Is Aurora Cannabis (ACB) Outperforming Other Medical Stocks This Year? (Zacks) +6.37%
Jan-09-23 07:00AM	Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus Safety Switch System in Cell Therapies for Autoimmune Disease (GlobeNewswire) +6.04%
Jan-05-23 08:00AM	Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-03-23 05:40AM	The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences (Zacks)
Dec-30-22 09:03AM	4 Drug Stocks That More Than Doubled This Year (Zacks)
Dec-23-22 09:40AM	Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year? (Zacks) -8.82%
Dec-13-22 11:41AM	Cabaletta Bio, Inc.'s (NASDAQ:CABA) largest shareholders are individual investors who were rewarded as market cap surged US$15m last week (Simply Wall St.)
Dec-12-22 01:37PM	Cabaletta Bio expects to complete $35M stock and warrant sale this week to advance cell therapy candidate (American City Business Journals) -7.72%
Dec-08-22 07:00AM	Cabaletta Bio Announces $35 Million Offering (GlobeNewswire)
Dec-07-22 09:55AM	Can Cabaletta Bio, Inc. (CABA) Climb 60% to Reach the Level Wall Street Analysts Expect? (Zacks) +10.40%
Nov-22-22 08:00AM	Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) +7.16%
Nov-16-22 11:26AM	As Cabaletta Bio, Inc. (NASDAQ:CABA) hits US$104m market cap, insiders may be dismayed about not purchasing higher quantities (Simply Wall St.) +5.88%
Nov-10-22 07:00AM	Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-11-22 10:06AM	IASO Biotherapeutics, Cabaletta Bio Ink License Pact For CD19 Binder (Benzinga)
07:00AM	Cabaletta Bio Announces CABA-201, a Newly Designed CD19-Targeting CAR T Cell Therapy Engineered to Address a Broad Range of Autoimmune Diseases (GlobeNewswire)
Oct-06-22 08:00AM	Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy (GlobeNewswire)
Oct-05-22 06:26AM	Will Cabaletta Bio (NASDAQ:CABA) Spend Its Cash Wisely? (Simply Wall St.)
Sep-26-22 08:00AM	Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-10-22 07:00AM	Cabaletta Bio Presents New Interim Data from the DesCAARTes Phase 1 Trial at the 31st EADV Congress (GlobeNewswire)
Sep-06-22 08:00AM	Cabaletta Bio to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
Aug-29-22 01:58PM	Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes Trial (GlobeNewswire) -33.95%
Aug-11-22 07:00AM	Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +13.28%
Jun-09-22 12:00PM	What Makes Cabaletta Bio, Inc. (CABA) a New Buy Stock (Zacks)
May-25-22 03:10PM	Why Did Mizuho Cut Price Target On This CAR-T Stock, But Remain Bullish (Benzinga)
May-18-22 12:49PM	Cabaletta Bio's Updated Interim DSG3-CAART Data Fails To Cheer Investors (Benzinga) -13.30%
07:00AM	Cabaletta Bio Presents Updated Interim DesCAARTes Trial Phase 1 Data at the ASGCT 25th Annual Meeting (GlobeNewswire)
May-17-22 08:00AM	Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-12-22 07:00AM	Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +7.32%
May-02-22 04:30PM	Cabaletta Bio to Present DSG3-CAART Clinical Data and MuSK-CAART Preclinical Data at Upcoming Scientific Meetings in May (GlobeNewswire)
Apr-15-22 08:03AM	Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? (Simply Wall St.)
Apr-06-22 08:00AM	Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-17-22 07:00AM	Cabaletta Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-04-22 02:34PM	Lab notes: Myonex acquires German drug business; Vallon receives Covid drug treatment patent (American City Business Journals)
Mar-01-22 08:00AM	U.S. Food and Drug Administration Grants Cabaletta Bio Fast Track Designation for MuSK-CAART (GlobeNewswire)
Feb-28-22 08:00AM	Cabaletta Bio to Participate in the Cowen Virtual 42nd Annual Health Care Conference (GlobeNewswire)
Jan-11-22 08:00AM	Cabaletta Bio Strengthens Executive Leadership Team with Promotions of Gwendolyn Binder, Ph.D. to President of Science and Technology and Arun Das, M.D. to Chief Business Officer (GlobeNewswire)
Jan-10-22 08:00AM	Cabaletta Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-04-22 10:00AM	Down 63.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Cabaletta Bio, Inc. (CABA) (Zacks)
Jan-03-22 08:00AM	Cabaletta Bio to Present at the H.C. Wainwright BioConnect Conference (GlobeNewswire)
Dec-14-21 07:00AM	Cabaletta Bio Reports Top-line Biologic Activity Data from Two Lowest Dose Cohorts in DesCAARTes Trial in Patients with Mucosal Pemphigus Vulgaris (GlobeNewswire) -73.14%
Nov-09-21 04:30PM	Cabaletta Bio to Participate in Upcoming Investor Conferences in November (GlobeNewswire)
08:00AM	Cabaletta Bio Expands Executive Leadership Team with Appointments of Samik Basu, M.D. to Chief Scientific Officer and Heather Harte-Hall, MSc. to Chief Compliance Officer (GlobeNewswire)
Nov-03-21 09:15AM	Wall Street Analysts Predict a 52% Upside in Cabaletta Bio, Inc. (CABA): Here's What You Should Know (Zacks)
Nov-01-21 07:05AM	Cabaletta Bio Reports Third Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire) +5.12%
07:00AM	Cabaletta Bio Reports Clinical Data from the Third Dose Cohort in DesCAARTes Trial in Patients with mPV (GlobeNewswire)
Oct-17-21 09:06AM	How Many Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Do Institutions Own? (Simply Wall St.)
Oct-15-21 04:30PM	Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential Precision Therapy for Antigen-Specific B Cell Depletion in PLA2R Membranous Nephropathy at ASN Kidney Week 2021 (GlobeNewswire)
Sep-28-21 08:00AM	Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-27-21 11:55AM	10 Cheap Pharmaceutical Stocks to Watch (Insider Monkey)
Sep-07-21 08:00AM	Cabaletta Bio Announces Appointment of Michael Gerard as General Counsel (GlobeNewswire)
Sep-02-21 08:00AM	Cabaletta Bio to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
Aug-18-21 08:57AM	Cabaletta Bio's Cell Therapy Shows Encouraging Safety Profile In Autoimmune Skin Disorder (Benzinga) +9.99%
07:00AM	Cabaletta Bio Reports Clinical Data from the Second Dose Cohort in DesCAARTes Trial in Patients with mPV (GlobeNewswire)
Aug-05-21 07:30AM	Cabaletta Bio Reports Second Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Jul-25-21 06:20PM	10 Best Medical Stocks Under $10 (Insider Monkey)
Jul-19-21 02:05AM	We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate (Simply Wall St.)
Jun-28-21 08:00AM	Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors (GlobeNewswire) +8.02%
May-27-21 08:00AM	Cabaletta Bio to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-03-21 01:17PM	Cabaletta Bio's Cell Therapy In Skin Blistering Disorder Shows Favorable Safety Profile (Benzinga)
07:05AM	Cabaletta Bio Reports First Quarter 2021 Financial Results and Provides New Pipeline Updates (GlobeNewswire)
07:00AM	Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes Trial (GlobeNewswire)
Apr-27-21 11:10AM	These 5 biotech busted IPOs look attractive now that the sectorwide selloff seems over (MarketWatch)
Apr-20-21 02:33AM	What Percentage Of Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Do Insiders Own? (Simply Wall St.)

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Binder Gwendolyn	See Remarks	Sep 19	Option Exercise	1.01	11,000	11,110	31,000	Sep 20 04:30 PM
Binder Gwendolyn	See Remarks	Sep 19	Sale	17.57	11,000	193,220	20,000	Sep 20 04:30 PM
Binder Gwendolyn	See Remarks	Aug 21	Option Exercise	1.01	11,000	11,110	31,000	Aug 22 04:30 PM
Binder Gwendolyn	See Remarks	Aug 21	Sale	13.42	11,000	147,583	20,000	Aug 22 04:30 PM
Binder Gwendolyn	See Remarks	Jul 19	Option Exercise	1.01	11,000	11,110	31,000	Jul 19 08:37 PM
Binder Gwendolyn	See Remarks	Jul 19	Sale	13.82	11,000	152,022	20,000	Jul 19 08:37 PM
Binder Gwendolyn	See Remarks	Jun 20	Option Exercise	1.01	11,000	11,110	31,000	Jun 21 04:38 PM
Binder Gwendolyn	See Remarks	Jun 20	Sale	12.99	11,000	142,925	20,000	Jun 21 04:38 PM
Binder Gwendolyn	See Remarks	May 19	Option Exercise	1.01	22,000	22,220	42,000	May 19 08:10 PM
Binder Gwendolyn	See Remarks	May 19	Sale	11.81	22,000	259,833	20,000	May 19 08:10 PM
Nichtberger Steven	President & CEO	Oct 19	Buy	1.25	8,127	10,152	986,483	Oct 19 08:19 PM
Nichtberger Steven	President & CEO	Oct 18	Buy	0.99	141,873	141,008	978,356	Oct 18 09:50 PM
Simon Mark	Director	Oct 18	Buy	0.98	118,000	115,286	136,144	Oct 18 09:50 PM
Marda Anup	Chief Financial Officer	Oct 18	Buy	0.99	50,000	49,620	50,000	Oct 18 09:50 PM
Binder Gwendolyn	See Remarks	Oct 18	Buy	0.99	20,000	19,894	20,000	Oct 18 09:50 PM
Simon Mark	Director	Oct 18	Buy	0.98	7,000	6,835	7,000	Oct 18 09:50 PM
Bollard Catherine	Director	Oct 18	Buy	0.99	1,000	994	1,000	Oct 18 09:51 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CABA | Cabaletta Bio Inc

Upgrade your FINVIZ experience